BEIJING BIOSTAR PHARMACEUTICALS COBEIJING BIOSTAR PHARMACEUTICALS COBEIJING BIOSTAR PHARMACEUTICALS CO

BEIJING BIOSTAR PHARMACEUTICALS CO

No trades
See on Supercharts

2563 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Beijing Biostar Pharmaceuticals Co. Ltd. engages in the provision of treatment for tumor. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
2563 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company